This session explores subjects and methodology that are wide-ranging, but that all are looking at the patient experience of disease and treatment beyond survival, which is often the focus of data collection and analysis. The studies explore treatment barriers, surrogate endpoints, patient preferences, and biomarkers.

Seating is limited.